JMS Co

JMS Co Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of JMS Co (7702.T) as of Nov 2, 2026 is -202.04 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 1,648.31 % — a change of -112.26% (lower).

Cash Conversion

-202.04 %

YoY

-112.26%

Last updated:

Cash Conversion Rate (OCF/Net Income) of JMS Co is 2026 -202.04 % . Cash Conversion Rate (OCF/Net Income) of JMS Co was 2025 1,648.31 % . It decreases by -112.26% lower compared to the previous year.

The JMS Co Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2019
375.26 JPY
Jan 1, 2020
180.32 JPY
Jan 1, 2021
215.38 JPY
Jan 1, 2022
532.57 JPY
Jan 1, 2023
884.34 JPY
Jan 1, 2024
-8,722.22 JPY
Jan 1, 2025
1,648.31 JPY
Jan 1, 2026
-202.04 JPY
The JMS Co Cash Conversion history
YEARCash ConversionYoY
-202.04 %-112.26%
1,648.31 %-118.90%
-8,722.22 %-1,086.30%
884.34 %+66.05%
532.57 %+147.27%
215.38 %+19.44%
180.32 %-51.95%
375.26 %-11.18%
422.50 %+6.82%
395.52 %-34.11%
600.27 %-71.24%
2,087.05 %+258.23%
582.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JMS Co Stock analysis

What does JMS Co do? JMS Co., Ltd. generates revenue through the manufacture, sale, export, and import of medical devices and pharmaceuticals across its five geographical segments: Japan, Singapore, China, Philippines, and Germany. The company offers a range of products including infusion and nutrition products, dialysis products, surgery products, blood and cell products, and other related items. Key products such as infusion & transfusion sets, syringe pumps, surgical gowns, dialysis kits, peritoneal dialysate, microcatheters, and blood bags are sold to healthcare providers and institutions within these regions. The firm also provides maintenance services and other related services as part of its product portfolio. The company's primary customers are healthcare providers and institutions in Japan, Singapore, China, Philippines, and Germany, where it operates through its five geographical segments. These customers purchase medical equipment and drugs, including specific items like infusion & transfusion sets, dialysis kits, and surgical gowns. The firm's product lines are tailored to meet the needs of hospitals, clinics, and other medical facilities across its operational regions. JMS Co., Ltd. focuses on manufacturing and selling medical equipment and drugs, with a strong emphasis on products such as infusion & transfusion sets, syringe pumps, surgical gowns, and dialysis kits. The company's revenue streams are driven by the sale of these products and the provision of maintenance services. Its geographical segments ensure a diversified market presence, allowing it to serve various healthcare sectors in different countries. JMS Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JMS Co stock

Cash Conversion Rate (OCF/Net Income) of JMS Co is -202.04 % in 2026.

Cash Conversion Rate (OCF/Net Income) of JMS Co changed from 1,648.31 % to -202.04 %, representing a -112.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) JMS Co since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s JMS Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — JMS Co

All Key Metrics — JMS Co